tiprankstipranks
Trending News
More News >
Honliv Healthcare Management Group Co Ltd (HK:9906)
:9906
Hong Kong Market
Advertisement

Honliv Healthcare Management Group Co Ltd (9906) AI Stock Analysis

Compare
1 Followers

Top Page

HK:9906

Honliv Healthcare Management Group Co Ltd

(9906)

Rating:58Neutral
Price Target:
HK$1.50
▲(0.00% Upside)
Honliv Healthcare's overall stock score is primarily influenced by its stable financial performance, which provides a solid foundation despite challenges in profitability. Technical analysis indicates bearish momentum, which negatively impacts the score. The valuation is moderate, with a reasonable P/E ratio but no dividend yield. The lack of earnings call data and corporate events means these factors do not influence the score.

Honliv Healthcare Management Group Co Ltd (9906) vs. iShares MSCI Hong Kong ETF (EWH)

Honliv Healthcare Management Group Co Ltd Business Overview & Revenue Model

Company DescriptionHonliv Healthcare Management Group Co Ltd (9906) is a healthcare management company based in China. The company operates in the healthcare sector, primarily focusing on the management and operation of hospitals and healthcare facilities. It provides comprehensive healthcare services including medical treatment, health management, and elderly care services. The company aims to deliver high-quality healthcare services to its clients through its network of managed facilities.
How the Company Makes MoneyHonliv Healthcare Management Group Co Ltd generates revenue primarily through the management and operation of hospitals and healthcare facilities. Its key revenue streams include patient services fees, which are collected for various medical treatments and healthcare services provided at its facilities. Additionally, the company may earn income from partnerships with governmental health programs or private insurance companies, enhancing its service offerings and patient reach. Revenue is also supplemented by providing specialized healthcare services such as health management programs and elderly care, which cater to a growing demand for comprehensive health solutions in China.

Honliv Healthcare Management Group Co Ltd Financial Statement Overview

Summary
Honliv Healthcare demonstrates stability through solid financial health, characterized by a strong balance sheet with low leverage and steady cash flow generation. While revenue growth is moderate, the company faces pressure on profit margins, indicating potential challenges in cost management. Overall, the financial position is robust, providing a firm foundation for future operations despite the need to enhance profitability metrics.
Income Statement
72
Positive
The company has shown steady revenue growth, with the latest annual growth rate at 1.08%. However, gross profit margin has decreased from 19.05% to 16.48% over the past year, indicating potential cost pressures. Net profit margin slightly decreased from 5.04% to 4.05%, suggesting some challenges in maintaining profitability. The EBIT and EBITDA margins have remained relatively stable, which is a positive sign for operational efficiency.
Balance Sheet
68
Positive
The balance sheet reveals a solid equity position with an equity ratio of 58.83% as of the latest report. The debt-to-equity ratio is low at 0.31, indicating low leverage and financial stability. However, the return on equity has decreased from 7.07% to 5.44% over the past year, reflecting a potential decline in shareholder returns.
Cash Flow
70
Positive
The company has demonstrated a strong recovery in free cash flow, growing from a negative position in earlier years to a positive $31.19 million in the latest year. The operating cash flow to net income ratio is robust at 2.68, illustrating effective cash generation relative to net income. However, the free cash flow to net income ratio has room for improvement at 1.00, indicating that not all profits are being converted into free cash.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue805.24M768.73M760.53M727.79M606.84M524.04M
Gross Profit146.51M126.69M144.84M138.40M135.31M137.59M
EBITDA118.11M125.80M119.31M127.13M98.20M79.43M
Net Income34.09M31.15M38.31M48.95M36.62M21.84M
Balance Sheet
Total Assets992.67M974.00M968.71M935.04M961.71M972.46M
Cash, Cash Equivalents and Short-Term Investments260.20M258.50M239.75M255.24M263.61M302.48M
Total Debt171.06M176.04M180.76M143.12M188.48M250.05M
Total Liabilities424.96M395.08M421.26M380.37M395.08M442.85M
Stockholders Equity561.90M573.00M541.85M549.47M561.83M525.21M
Cash Flow
Free Cash Flow29.23M31.19M2.01M98.66M40.08M-6.24M
Operating Cash Flow102.49M83.34M91.56M118.47M91.44M74.61M
Investing Cash Flow-73.94M-51.38M-88.76M-19.16M-50.46M-80.06M
Financing Cash Flow-42.56M-13.30M-19.12M-117.85M-76.87M215.16M

Honliv Healthcare Management Group Co Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.50
Price Trends
50DMA
1.50
Negative
100DMA
1.51
Negative
200DMA
1.69
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
21.81
Positive
STOCH
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:9906, the sentiment is Negative. The current price of 1.5 is below the 20-day moving average (MA) of 1.50, below the 50-day MA of 1.50, and below the 200-day MA of 1.69, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 21.81 is Positive, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:9906.

Honliv Healthcare Management Group Co Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
HK$665.44M40.041.07%8.04%-1.20%-87.51%
66
Neutral
HK$1.64B5.0824.13%4.37%-3.85%-19.28%
58
Neutral
HK$900.00M24.395.60%-0.83%-18.97%
55
Neutral
HK$428.89M20.432.73%2.48%-0.69%
54
Neutral
HK$1.22B46.851.27%-4.30%13.83%
51
Neutral
$7.86B-0.26-41.41%2.22%22.87%-2.01%
48
Neutral
HK$934.19M-10.78%-0.95%-128.35%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:9906
Honliv Healthcare Management Group Co Ltd
1.50
-0.52
-25.74%
HK:1419
Human Health Holdings Ltd.
1.13
0.15
15.31%
HK:1526
Rici Healthcare Holdings Ltd.
0.98
-0.15
-13.27%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
1.99
-0.41
-17.08%
HK:3869
Hospital Corporation of China Ltd
6.50
2.70
71.05%
HK:6639
Arrail Group Ltd.
2.16
-1.17
-35.14%

Honliv Healthcare Management Group Co Ltd Corporate Events

Honliv Healthcare Management Group’s AGM Approves Key Resolutions
Jun 13, 2025

Honliv Healthcare Management Group Co Ltd held its annual general meeting on June 13, 2025, where all proposed resolutions were passed with unanimous approval. Key resolutions included the re-election of directors, authorization of directors’ remuneration, reappointment of PricewaterhouseCoopers as auditors, and granting mandates for share repurchase and issuance. These decisions reflect strong shareholder support and are likely to enhance the company’s governance and operational flexibility.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 12, 2025